Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» QR Pharma announces FDA clearance to begin trials related to Alzheimer compound
QR Pharma announces FDA clearance to begin trials related to Alzheimer compound
QR Pharma announces FDA clearance to begin trials related to Alzheimer compound
Submitted by
admin
on December 4, 2010 - 12:40pm
Source:
Behavioral Health Central
News Tags:
QR Pharma
Alzheimer's disease
bisnorcymserine
butyrylcholinesterase inhibition
Headline:
QR Pharma announces FDA clearance to begin trials related to Alzheimer compound
Do Not Allow Advertisers to Use My Personal information
